Michael Kaplan

7.6k total citations
136 papers, 5.2k citations indexed

About

Michael Kaplan is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Michael Kaplan has authored 136 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Pediatrics, Perinatology and Child Health, 70 papers in Pulmonary and Respiratory Medicine and 42 papers in Molecular Biology. Recurrent topics in Michael Kaplan's work include Neonatal Health and Biochemistry (82 papers), Methemoglobinemia and Tumor Lysis Syndrome (63 papers) and Heme Oxygenase-1 and Carbon Monoxide (38 papers). Michael Kaplan is often cited by papers focused on Neonatal Health and Biochemistry (82 papers), Methemoglobinemia and Tumor Lysis Syndrome (63 papers) and Heme Oxygenase-1 and Carbon Monoxide (38 papers). Michael Kaplan collaborates with scholars based in Israel, United States and Italy. Michael Kaplan's co-authors include Cathy Hammerman, David K. Stevenson, Ruben Bromiker, Alona Bin‐Nun, Hendrik J. Vreman, Robert J. Johnson, Bernard Rudensky, Braden C. Fleming, Paul Renbaum and Michael S. Caplan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Hepatology and PEDIATRICS.

In The Last Decade

Michael Kaplan

134 papers receiving 4.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Michael Kaplan 3.0k 2.2k 1.3k 1.2k 675 136 5.2k
Uri S. Alon 843 0.3× 1.1k 0.5× 712 0.5× 373 0.3× 208 0.3× 144 3.6k
Luciano Cavallo 600 0.2× 372 0.2× 1.1k 0.8× 1.0k 0.9× 350 0.5× 133 4.3k
Gary M. Chan 734 0.2× 797 0.4× 483 0.4× 523 0.4× 349 0.5× 81 3.7k
Yun Sil Chang 1.8k 0.6× 3.2k 1.4× 936 0.7× 1.7k 1.5× 149 0.2× 301 5.7k
Ichiro Morioka 890 0.3× 511 0.2× 874 0.7× 313 0.3× 157 0.2× 309 2.9k
J. S. Wigglesworth 2.4k 0.8× 2.2k 1.0× 296 0.2× 1.4k 1.2× 199 0.3× 112 5.1k
Costantino Romagnoli 1.8k 0.6× 1.9k 0.9× 444 0.3× 821 0.7× 238 0.4× 231 4.3k
Yoichi Kohno 264 0.1× 752 0.3× 1.2k 0.9× 1.0k 0.9× 958 1.4× 256 5.2k
Edgar L. Makowski 2.0k 0.6× 864 0.4× 257 0.2× 428 0.4× 435 0.6× 93 4.3k
Helen G. Liley 719 0.2× 1.2k 0.6× 373 0.3× 499 0.4× 197 0.3× 97 2.7k

Countries citing papers authored by Michael Kaplan

Since Specialization
Citations

This map shows the geographic impact of Michael Kaplan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kaplan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kaplan more than expected).

Fields of papers citing papers by Michael Kaplan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kaplan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kaplan. The network helps show where Michael Kaplan may publish in the future.

Co-authorship network of co-authors of Michael Kaplan

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kaplan. A scholar is included among the top collaborators of Michael Kaplan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kaplan. Michael Kaplan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kaplan, Michael, Ronald J. Wong, & David K. Stevenson. (2018). Hemolysis and Glucose-6-Phosphate Dehydrogenase Deficiency-Related Neonatal Hyperbilirubinemia. Neonatology. 114(3). 223–225. 16 indexed citations
3.
Algur, Nurit, et al.. (2015). Glucose-6-Phosphate Dehydrogenase Screening in Israel-Arab and Palestinian-Arab Neonates. The Journal of Pediatrics. 167(1). 169–172. 9 indexed citations
4.
Kaplan, Michael, Cathy Hammerman, & Vinod K. Bhutani. (2015). Parental education and the WHO neonatal G-6-PD screening program: a quarter century later. Journal of Perinatology. 35(10). 779–784. 20 indexed citations
5.
Algur, Nurit, et al.. (2012). Quantitative Neonatal Glucose-6-Phosphate Dehydrogenase Screening: Distribution, Reference Values, and Classification by Phenotype. The Journal of Pediatrics. 161(2). 197–200. 35 indexed citations
6.
Kaplan, Michael, Cathy Hammerman, Hendrik J. Vreman, Ronald J. Wong, & David K. Stevenson. (2010). Hemolysis and Hyperbilirubinemia in Antiglobulin Positive, Direct ABO Blood Group Heterospecific Neonates. The Journal of Pediatrics. 157(5). 772–777. 53 indexed citations
7.
Kaplan, Michael, Paul Merlob, & Rivka Regev. (2008). Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus. Journal of Perinatology. 28(6). 389–397. 59 indexed citations
8.
Kaplan, Michael, Paul Renbaum, Hendrik J. Vreman, et al.. (2007). (TA)n UGT 1A1 Promoter Polymorphism: A Crucial Factor in the Pathophysiology of Jaundice in G-6-PD Deficient Neonates. Pediatric Research. 61(6). 727–731. 27 indexed citations
9.
Bromiker, Ruben, et al.. (2006). Immature sucking patterns in infants of mothers with diabetes. The Journal of Pediatrics. 149(5). 640–643. 34 indexed citations
10.
Kaplan, Michael, et al.. (2005). American Academy of Pediatrics guidelines for detecting neonatal hyperbilirubinaemia and preventing kernicterus. Archives of Disease in Childhood Fetal & Neonatal. 90(6). F448–F449. 16 indexed citations
11.
Kaplan, Michael & Cathy Hammerman. (2005). Understanding severe hyperbilirubinemia and preventing kernicterus: Adjuncts in the interpretation of neonatal serum bilirubin. Clinica Chimica Acta. 356(1-2). 9–21. 62 indexed citations
12.
Kaplan, Michael & Cathy Hammerman. (2004). Glucose-6-phosphate dehydrogenase deficiency: A hidden risk for kernicterus. Seminars in Perinatology. 28(5). 356–364. 70 indexed citations
13.
Kaplan, Michael, Cathy Hammerman, Firmino F. Rubaltelli, et al.. (2002). Hemolysis and bilirubin conjugation in association with UDP-glucuronosyltransferase 1A1 promoter polymorphism. Hepatology. 35(4). 905–911. 40 indexed citations
14.
Hammerman, Cathy, D. Goldschmidt, Michael S. Caplan, et al.. (2002). Protective Effect of Bilirubin in Ischemia‐Reperfusion Injury in the Rat Intestine. Journal of Pediatric Gastroenterology and Nutrition. 35(3). 344–349. 2 indexed citations
15.
Hammerman, Cathy, Michael S. Caplan, Michael Kaplan, et al.. (1999). Amelioration of Ischemia‐Reperfusion Injury in Rat Intestine by Pentoxifylline‐Mediated Inhibition of Xanthine Oxidase. Journal of Pediatric Gastroenterology and Nutrition. 29(1). 69–74. 1 indexed citations
16.
Anthony, James P., Robert D. Foster, Michael Kaplan, Mark I. Singer, & M. Anthony Pogrel. (1997). Fibular Free Flap Reconstruction of the “True” Lateral Mandibular Defect. Annals of Plastic Surgery. 38(2). 137–146. 21 indexed citations
17.
Kaplan, Michael, et al.. (1996). CONTRIBUTION OF HAEMOLYSIS TO JAUNDICE IN SEPHARDIC JEWISH GLUCOSE‐6‐PHOSPHATE DEHYDROGENASE DEFICIENT NEONATES. British Journal of Haematology. 93(4). 822–827. 53 indexed citations
18.
Kaplan, Michael, Firmino F. Rubaltelli, Cathy Hammerman, et al.. (1996). Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiency. The Journal of Pediatrics. 128(5). 695–697. 57 indexed citations
19.
Kaplan, Michael, et al.. (1995). Antacid Bezoar in a Premature Infant. American Journal of Perinatology. 12(2). 98–99. 10 indexed citations
20.
Kaplan, Michael, et al.. (1985). Neonatal hypoglycemia related to umbilical artery catheter malposition. The Journal of Pediatrics. 106(5). 825–826. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uri S. Alon Breakdown of academic impact, for papers by Luciano Cavallo Breakdown of academic impact, for papers by Gary M. Chan Breakdown of academic impact, for papers by Yun Sil Chang Breakdown of academic impact, for papers by Ichiro Morioka Breakdown of academic impact, for papers by J. S. Wigglesworth Breakdown of academic impact, for papers by Costantino Romagnoli Breakdown of academic impact, for papers by Yoichi Kohno Breakdown of academic impact, for papers by Edgar L. Makowski Breakdown of academic impact, for papers by Helen G. Liley
Rankless by CCL
2026